explore -WSS

explore

author：fashion 2025-10-01 11:02:12 - browse：31514

the Federal Trade Commission building and its brown sign — Adobe

A federal judge ordered Wednesday that Novant Health can move forward with its plan to buy two North Carolina hospitals, denying the Federal Trade Commission’s request for an injunction.

The FTC sued to block the deal in January, arguing that it would give Novant control of more than 65% of the region’s inpatient market. The case, one seeking to block nearby hospitals from merging and creating an even more powerful dominant player, is the FTC’s bread and butter. The agency has shied away from challenging cross-market and vertical mergers, but this one is right in its wheelhouse, which makes the setback surprising.

Under the deal, announced early last year, Novant would buy two hospitals in the same county from for-profit Community Health Systems for $320 million. The hospitals, Lake Norman Regional Medical Center and Davis Regional Medical Center, are only a 25-minute drive from one another. Davis Regional used to be a full-service hospital, but is now a psychiatric hospital. The deal also includes a group of 24 doctors, a majority interest in an endoscopy center, and a holding in a planned surgery center.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Study: Lilly Alzheimer's therapy slowed patients' cognitive decline

knowledge

focus

WSS

FDA approves first new drug developed for postpartum depression

Why we need to separate burnout from moral injury in health care

3 hurdles to bringing medical devices to the U.S. market

3 hurdles to bringing medical devices to the U.S. market

FDA grants conditional OK to Sarepta’s gene therapy for Duchenne

How to fix the rural physician shortage in the U.S.

focus

explore

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

explore

Activists slam private health insurers over coverage restrictions

How to fix the rural physician shortage in the U.S.

Medical leaders decry Supreme Court decision on affirmative action

New guidelines on severe brain injury complicate already difficult decisions

Affirmative action in medical school literally saved lives

Weight bias in eating disorder treatment complicated by new weight loss drugs

Alkermes shareholders re

Study: Lilly Alzheimer's therapy slowed patients' cognitive decline

The cancer drug shortage isn’t new — and neither are the solutions

Patients, doctors are clashing about side effects of hormonal birth control

knowledge

Inside the rise of 'mukbang' eating videos

Weight bias in eating disorder treatment complicated by new weight loss drugs

The battle over the Brookhaven Landfill on Long Island

Obesity experts on risks of Wegovy, Ozempic weight loss drugs

CDC concerned about possible undetected monkeypox spread in U.K.

Colonoscopy at 40? Study finds a possible benefit

focus

knowledge

focus

hotspot